Neuronetics, Inc.

Neuronetics, Inc. company information, Employees & Contact Information

Neuronetics, Inc., is the creator of NeuroStar Advanced Therapy, the market leader in Transcranial Magnetic Stimulation (TMS) for the treatment of Major Depressive Disorder and other mental health conditions. Based in Malvern, PA, we are a public medical device company (STIM) with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in the world. NeuroStar is the #1 TMS choice of doctors, with over 6.4 million treatments performed to date. It is an advanced treatment for depression and other mental health conditions. It is not medication, shock therapy, or surgery. NeuroStar is an outpatient treatment done in as little as 20 minutes for 36 sessions. It promotes neuroplasticity to target mental health where it starts — the brain. Neuronetics markets NeuroStar Advanced Therapy throughout the United States and select markets around the world. If you have questions or comments about NeuroStar, please e-mail us at customersupport@neurostar.com. For U.S. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207. Please visit NeuroStar.com/Safety for full safety and prescribing information.

Company Details

Employees
219
Address
3222 Phoenixville Pike, Malvern,pa 19355,united States
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Malvern, PA
Looking for a particular Neuronetics, Inc. employee's phone or email?

Neuronetics, Inc. Questions

News

5 Million NY Medicaid Members Gain Access to Breakthrough Depression Treatment NeuroStar TMS - Stock Titan

5 Million NY Medicaid Members Gain Access to Breakthrough Depression Treatment NeuroStar TMS Stock Titan

Neuronetics, Inc. CEO Keith Sullivan to Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 | STIM Stock News - Quiver Quantitative

Neuronetics, Inc. CEO Keith Sullivan to Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 | STIM Stock News Quiver Quantitative

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call - The Manila Times

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call The Manila Times

Melissa Fickey, MD: Owner of Embracing Life Wellness Center - Tampa Magazine

Melissa Fickey, MD: Owner of Embracing Life Wellness Center Tampa Magazine

Neuronetics Sets Q2 2025 Earnings Date: Leading Neurohealth Tech Company to Share Latest Financial Results - Stock Titan

Neuronetics Sets Q2 2025 Earnings Date: Leading Neurohealth Tech Company to Share Latest Financial Results Stock Titan

NeuroStar Presents Transcranial Magnetic Stimulation: Solutions for Major Depressive Disorder Beyond Medication - Psychiatric Times

NeuroStar Presents Transcranial Magnetic Stimulation: Solutions for Major Depressive Disorder Beyond Medication Psychiatric Times

TMS Device NeuroStar Cleared for Obsessive-Compulsive Disorder - Medical Professionals Reference

TMS Device NeuroStar Cleared for Obsessive-Compulsive Disorder Medical Professionals Reference

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call - The Manila Times

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call The Manila Times

Neuronetics, Inc. Grants Inducement Awards to New Employee as Part of Compensation Plan - Nasdaq

Neuronetics, Inc. Grants Inducement Awards to New Employee as Part of Compensation Plan Nasdaq

Neuronetics Appoints Lisa Metzner-Rosas as SVP, Chief Marketing Officer - citybiz

Neuronetics Appoints Lisa Metzner-Rosas as SVP, Chief Marketing Officer citybiz

Depression therapy providing hope without side effects of medication - WBMA

Depression therapy providing hope without side effects of medication WBMA

New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction - GlobeNewswire

New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction GlobeNewswire

TMS Device NeuroStar Cleared for Anxious Depression - Medical Professionals Reference

TMS Device NeuroStar Cleared for Anxious Depression Medical Professionals Reference

Neuronetics, Inc. Announces Q3 2025 Financial Results Release and Conference Call Schedule - Quiver Quantitative

Neuronetics, Inc. Announces Q3 2025 Financial Results Release and Conference Call Schedule Quiver Quantitative

FDA Clears NeuroStar TMS for Treatment of MDD in Adolescents - Psychiatric Times

FDA Clears NeuroStar TMS for Treatment of MDD in Adolescents Psychiatric Times

Neuronetics Appoints Steven Pfanstiel as Chief Financial Officer - citybiz

Neuronetics Appoints Steven Pfanstiel as Chief Financial Officer citybiz

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression - Stock Titan

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression Stock Titan

Neuronetics Expands Leadership Team with 31,650 RSU Grants: Major Push in Neurohealth Tech - Stock Titan

Neuronetics Expands Leadership Team with 31,650 RSU Grants: Major Push in Neurohealth Tech Stock Titan

Neuronetics Appoints Steven Pfanstiel as New Chief Financial Officer, Reiterates Financial Guidance for 2025 - Quiver Quantitative

Neuronetics Appoints Steven Pfanstiel as New Chief Financial Officer, Reiterates Financial Guidance for 2025 Quiver Quantitative

Roadblocks to Treatment for People Suffering from Depression Continue to be Lifted with Next Generation NeuroStar® Advanced Therapy - PR Newswire

Roadblocks to Treatment for People Suffering from Depression Continue to be Lifted with Next Generation NeuroStar® Advanced Therapy PR Newswire

Neuronetics Appoints Joseph H. Capper to its Board of Directors - citybiz

Neuronetics Appoints Joseph H. Capper to its Board of Directors citybiz

Neuronetics (NASDAQ: STIM) to release results Nov. 4; conference call at 8:30 a.m. ET - Stock Titan

Neuronetics (NASDAQ: STIM) to release results Nov. 4; conference call at 8:30 a.m. ET Stock Titan

NeuroStar® Advanced Therapy Survey Finds Majority of Americans Don't Feel Very Equipped to Discuss Depression With Loved Ones - PR Newswire

NeuroStar® Advanced Therapy Survey Finds Majority of Americans Don't Feel Very Equipped to Discuss Depression With Loved Ones PR Newswire

Comparison of coil placement approaches targeting dorsolateral prefrontal cortex in depressed adolescents receiving repetitive transcranial magnetic stimulation: an electric field modeling study - medRxiv

Comparison of coil placement approaches targeting dorsolateral prefrontal cortex in depressed adolescents receiving repetitive transcranial magnetic stimulation: an electric field modeling study medRxiv

Neuronetics and Greenbrook TMS Announce Closing of Transaction - Stock Titan

Neuronetics and Greenbrook TMS Announce Closing of Transaction Stock Titan

Neuronetics Completes Acquisition of Greenbrook TMS, Creating a Combined Leader in Mental Health Therapy - Quiver Quantitative

Neuronetics Completes Acquisition of Greenbrook TMS, Creating a Combined Leader in Mental Health Therapy Quiver Quantitative

Neuronetics CEO Showcases Neurohealth Innovation at Major Growth Conference - Stock Titan

Neuronetics CEO Showcases Neurohealth Innovation at Major Growth Conference Stock Titan

Neuronetics® Unveils Promising New Depression Research Data at Psych Congress - PR Newswire

Neuronetics® Unveils Promising New Depression Research Data at Psych Congress PR Newswire

Non-drug solutions for postpartum depression: an interview with Dr David Brock & Christopher Thatcher - News-Medical

Non-drug solutions for postpartum depression: an interview with Dr David Brock & Christopher Thatcher News-Medical

Can brain stimulation aid memory and brain health? - Harvard Health

Can brain stimulation aid memory and brain health? Harvard Health

STIM Stock Price and Chart — NASDAQ:STIM - TradingView

STIM Stock Price and Chart — NASDAQ:STIM TradingView

Top Neuronetics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant